Insider Trading History of Capello Jeffrey D

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Capello Jeffrey D since 2019. This trader's CIK number is 1224108. At the time of last reporting, Capello Jeffrey D was the Director of Agios Pharmaceuticals, Inc.. (stock ticker symbol AGIO). Also see all insider trading activities at Agios Pharmaceuticals, Inc..

Note that in the past CAPELLO JEFFREY D also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Agios Pharmaceuticals, Inc. (AGIO) by Capello Jeffrey D

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2025 AGIO 0 $0 0 $0 4,097 $0

Yearly summary of insider trading at Biogen Inc. (BIIB) by Capello Jeffrey D

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2020 BIIB 0 $0 0 $0 3,221 $0
2019 BIIB 0 $0 0 $0 1,331 $0

Yearly summary of insider trading at Neogen Corp (NEOG) by Capello Jeffrey D

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2025 NEOG 20,712 $100,225 0 $0 0 $0
2024 NEOG 0 $0 0 $0 3,846 $55,720


Insider trading activities at 3 companies by Capello Jeffrey D:

1. Agios Pharmaceuticals, Inc. (AGIO)

2. Biogen Inc. (BIIB)

3. Neogen Corp (NEOG)

Table 1. Insider trading of Agios Pharmaceuticals, Inc. (AGIO) by Capello Jeffrey D

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2025-06-20 AGIO Option Ex 2,120 .00 0
2025-06-13 AGIO Option Ex 1,977 .00 0

Table 2. Insider trading of Biogen Inc. (BIIB) by Capello Jeffrey D

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2020-02-12 BIIB Option Ex 1,919 .00 0
2020-01-02 BIIB Option Ex 1,302 .00 0
2019-01-02 BIIB Option Ex 1,331 .00 0

Table 3. Insider trading of Neogen Corp (NEOG) by Capello Jeffrey D

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2025-04-22 NEOG Buy 20,712 4.84 100,225
2024-10-28 NEOG Option Ex 1,776 13.81 24,526
2024-10-07 NEOG Option Ex 2,070 15.07 31,194

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Capello Jeffrey D (Director of Agios Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.